Prognostic parameters in carcinosarcomas of the uterus: A clinico-pathologic study

Anticancer Research

Volumn 21, Issue 4 B, 2001, Pages 3069-3074

  Bodner Adler, B ^a   Bodner, K ^a   Obermair, A ^a   Czerwenka, K ^a   Petru, E ^a   Leodolter, S ^a   Mayerhofer, K ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Carcinosarcoma; Prognostic parameters; Uterus

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER GROWTH; CANCER INVASION; CANCER MORTALITY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CARCINOSARCOMA; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MENOPAUSE; MULTICENTER STUDY; MYOMETRIUM; PARITY; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; UTERUS SARCOMA;

ADULT; AGED; AGED, 80 AND OVER; BRACHYTHERAPY; CARCINOSARCOMA; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYSTERECTOMY; MENOPAUSE; MIDDLE AGED; MYOMETRIUM; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PARITY; PROGNOSIS; RADIOISOTOPE TELETHERAPY; RADIOTHERAPY, ADJUVANT; SURVIVAL ANALYSIS; SURVIVAL RATE; UTERINE NEOPLASMS;

EID: 0035169864     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Mixed mesodermal sarcoma of the uterus
2. Patterns of recurrence in malignant mixed mullerian tumors of the ubrus
3. Clinicopathologic analysis of uterine malignant mullerian tumors
4. Malignant mixed mullerian tumors of the uterus: A clinicopathologic, DNA flow cytometric, p 53 and/mdm-2 analysis of 44 cases
5. Malignant mixed mullerian tumors of the uterus
6. Management of malignant mixed mesodermal tumors of the uterus
7. Carcinosarcoma of the uterus: A clinicopatholoogical multicenter CTF study
8. Treatment of uterine sarcomas with Adriamycin
9. A randomized clinical trial of adjuvant adriamycin in uterine sarcoma: A G.O.G. study
10. A phase II study of etoposide, cisplatin and doxorubicin chemotherapy in mixed mullerian tumors (MMT) of the uterus
11. Cisplatin and adriamycin combination chemotherapy for uterine stromal sarcomas and mixed mesodermal tumors
12. Prognostic features of sarcomas and mixed tumors of the endometrium
13. The impact of adjuvant radiotherapy on carcinosarcoma of the uterus
14. Nonparametric estimation from incomplete observations
15. Mesenchymal tumors of the uterus
16. Carcinosarcoma and mixed mesodermal tumor of the uterine corpus
17. Malignant mullerian tumours of the uterus
18. Parity as an independent prognostic factor in malignant mesodermal tumors of the endometrium
19. Prognostic factors in malignant mesodermal (mullerian) mixed tumors of the uterus
20. Mixed mullerian tumors of the uterus: A clinicopathologic study
21. Leiomyosarcomas have a poorer prognosis than mesodermal tumors when adjusting for known prognostic factors: The results of a retrospective study of 423 cases of uterine sarcoma
22. A multivariate analysis of clinicopathologic factors for predicting outcome in uterine sarcomas
23. Mixed mullerian tumours of the uterus- prognostic factors. A clinical and histopathological study of 147 cases
24. Prognostic factors in uterine carcinosarcoma: A clinicopathologic study of 25 patients
25. Prognostic factors for malignant mixed mullerian tumors of the uterus
26. An evaluation of prognostic factors in uterine carcinosarcoma
27. Uterine sarcomas analysis of failures with special emphasis on the use of adjuvant radiation therapy
28. Treatment, results, and prognostic factors in stage I and II sarcomas of the corpus uteri
29. Effects of irradiation on mixed mullerian tumors of the uterus
30. Survival, patterns of spread and prognostic factors in uterine sarcoma: A study of 76 patients